Solitary fibrous tumors of the oral and maxillofacial region: a case series from a single-center Authors: Chaowei Wang, Bo Wang, Jianfeng He Published: 2024 ABSTRACT BackgroundSolitary fibrous tumor (SFT) is a rare mesenchymal lesion that has a wide anatomic distribution. However, this lesion rarely occurs in the oral or maxillofacial region.MethodsA retrospective review was performed to evaluate the clinical symptoms, radiological images, pathology and immunohistochemistry results of 9 patients with SFTs treated between January 2015 to April 2024 in our institute. Surgical tumor resection was administered to all patients. Follow-up for these patients spanned until the conclusion of April 2024.ResultsThe series contained 3 males and 6 females, with the mean age 50.6 years (range: 25 to 73 years). The tumors were distributed at six different sites, including the tongue, submandibular region, cheek, sublingual gland, mandible, and hard palate. Clinically, the mass grew gradually and usually without obvious clinical symptoms. On imaging examination, the boundaries of all the tumors were clear, except for one patient with a mandibular tumor. Surgical excision was performed in all patients. Histological characteristics and positive immunostaining for STAT6, CD99, CD34 and Bcl-2 were the most important criteria for a final diagnosis. All tumors were positive for CD34 and Bcl-2. Only one tumor was negative for STAT6. While CD99 was negative in one case and weakly positive in two cases. All patients had no local recurrence during the follow-up period ranging from 1 to 100 months (mean 41.4 months).ConclusionsBenign SFTs occurring in the oral and maxillofacial region are rare, and surgery is the primary treatment for this tumor. It usually presents as a distinctly bordered heterogeneous mass on imaging. The tumors can compress surrounding bone tissue leading to bone resorption, and in rare cases, it may exhibit invasive resorption. SFTs should be included in the differential diagnosis of lesions in the oral and maxillofacial region. Background Solitary fibrous tumors (SFTs) are rare soft tissue tumors with an annual incidence of one case per million people [1]. Initially, SFTs were considered exclusive to the pleura. Over time, it was discovered that SFTs can be located at various anatomical sites throughout the body, including the meninge, peritoneum, abdominal cavity, trunk, limb, head and neck [2, 3]. SFTs in the head and neck account for approximately 6% of the total cases, highlighting the greater rarity of cases in the oral and maxillofacial areas [2]. The pathological diagnosis of SFTs has been refined over a long period. Initially, SFTs were classified as hemangiopericytomas, and it was not until 1931 that researchers proposed SFT as a distinct and independent disease. At that time, the diagnosis mainly relied on the histological morphology of the tumor, which is characterized by haphazardly arranged spindle-shaped tumor cells and abundant blood vessels with a “staghorn” appearance. The introduction of immunohistochemical techniques revealed that SFTs commonly express cluster of differentiation 34 (CD34), CD99 and B‐cell lymphoma 2 (Bcl‐2). Reportedly, 80–90% of SFTs can be correctly diagnosed based on histological features and immunohistochemical staining of CD34, CD99 and Bcl-2 [4]. In 2013, the importance of signal transducer and activator of transcription 6 (STAT6) in SFT diagnosis was discovered [5, 6]. When STAT6 detection with immunohistochemistry was added, the diagnostic accuracy improved to over 90% [7–9]. Subsequently, STAT6 has been widely applied as a novel diagnostic marker in clinical pathology. Pathologically, a nuclear mitotic count of less than 4 mitoses/10 high-power fields (HPFs) is considered low risk. When the count exceeds this level and is accompanied by certain presentations such as unclear borders, hypercellularity and necrosis, the tumor can be malignant. Very few reports have described malignant SFTs in the oral cavity, accounting for approximately 9.3% of oral SFTs [10]. SFTs do not exhibit clinical symptoms distinctive to the oral and maxillofacial regions. The majority of SFTs throughout the body are benign, including those in the oral and maxillofacial region [10]. On physical examination, SFTs typically present with clear borders and good mobility. The tumor usually grows slowly. In the early stages of the disease, patients may be completely unaware of the tumor due to its small size. As the tumor grows, patients are able to feel the mass and may experience facial asymmetry. When the tumor reaches a considerable size and exerts pressure on vital structures, patients may experience diverse symptoms, such as pain, numbness, and even difficulty swallowing and breathing. In addition, SFTs do not have typical radiological features and exhibit similarities with common benign soft tumors. The unique characteristic of the oral and maxillofacial region is the presence of abundant hard tissue, including the maxilla, mandible, and teeth. In our work, tumors of three patients had induced bone resorption and exhibited invasiveness, while tumors of other six patients were located within soft tissue. Hence, this manuscript will comprehensively descript this series of cases and discuss the clinical prediction, diagnosis, and treatment options for SFTs by combining all our cases and previous studies. Methods Patients and treatments During the period from January 2015 to April 2024, only nine patients were diagnosed with SFTs in the oral and maxillofacial region among the surgical patients in our department. The tumors were distributed at six different sites, including the tongue, submandibular region, cheek, sublingual gland, mandible, and hard palate. The research was performed according to the Declaration of Helsinki. The study protocol was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (IIT20240644A). All patients were received surgical treatment and underwent regular follow-up postoperatively. Radiological examination The color ultrasonography and magnetic resonance imaging (MRI) were employed for the examination of tumors within soft tissue. The computed tomography (CT) was utilized to assess the relationship between tumors and surrounding bone. The panoramic X-ray and Cone-beam computed tomography (CBCT) were employed to analyze the relationship between tumors and teeth, mandible and maxilla. Pathological examination Hematoxylin and eosin (HE) staining and immunohistochemical analysis were performed on tumor tissue sections. The immunohistochemical markers included STAT6, CD34, CD99, Bcl-2, cytokeratin (CK), Desmin, smooth muscle actin (SMA), S-100 and Ki-67. Results Case presentations for patients Patient 1 A 60-year-old Chinese female presented at our hospital with an asymptomatic mandibular lesion in left body of the mandible, which was occasionally noted by her dentist. The patient did not experience pain, numbness or other subjective symptoms. Intraoral examination revealed no mass in the left mandibular tooth arch, and the mucosa was normal. Panoramic X-ray revealed a unilocular radiolucent area in the left mandible with tooth root resorption of the third molar, and the lesion invaded the inferior alveolar neural canal (Fig. 1A). CBCT was performed and confirmed the radiolucency in the left mandible, with an irregular jagged edge, deficiency of the lingual side bone and a thinned buccal side bone (Fig. 1B). Based on the clinical and radiological data, a clinical diagnosis of “odontogenic keratocyst, ameloblastoma or giant cell tumor of the mandible” was made.Fig. 1Panoramic X-ray (A) and CBCT (B) images showing radiolucency (white arrows) with irregular jagged edges in the left lower jaw. L: left Panoramic X-ray (A) and CBCT (B) images showing radiolucency (white arrows) with irregular jagged edges in the left lower jaw. L: left The tumor was excised under general anesthesia. However, the patient refused bone grafting surgery, and enucleation surgery of the lesion was performed. During surgery, a mass with an unclear capsule was found in the mandible. Notably, the muscle tissue from the floor of the mouth on the lingual side was tightly adhered to the tumor. On histological examination, the soft tissue tumor was composed of alternating hypocellular and hypercellular areas. In the hypercellular areas, the spindle cells were disordered with fewer stroma. Immunohistochemical analysis revealed that the tumor was positive for STAT6, CD34, CD99, and Bcl-2 and negative for CK, S-100 and Desmin. The expression of SMA was weakly positive. The percentage of Ki-67-positive cells was about 1%. The nuclear mitotic count was 2–3 mitoses/10 HPF. Based on the pathological examination and clinical history, the diagnosis was determined to be a benign SFT with invasive growth. One year after surgery, the patient remains asymptomatic with no evidence suggesting recurrence or metastasis. Patient 2 A 44-year-old Chinese male presented with a neoplasm in the hard palate that had persisted for more than three months. The neoplasm caused a slightly sensation of a foreign body while swallowing but without pain or numbness. Intraoral examination revealed a tough oval-shaped mass located on the right hard palate with a clear boundary, approximately 3.0 × 2.0 cm in size. The overlying mucosa was normal. On palpable examination, no enlarged lymph nodes were detected in the submandibular or neck regions. CBCT revealed bone deficiency with somewhat irregular edges in the right hard palate without definite bone sclerotic lines (Fig. 2A-C). Based on clinical and radiological examinations, a clinical diagnosis of “palatal pleomorphic adenoma or adenoid cystic carcinoma” was made.Fig. 2The CBCT images for Patient 2. A-C Images showed a mass located on the right hard palate with palatal bone resorption (white arrows). D-F Images revealed the formation of new bone (white arrows) in the right hard palate 18 months after surgery. A and D: Transverse plane, B and E: Sagittal plane, C and F: Coronal plane. L: left The CBCT images for Patient 2. A-C Images showed a mass located on the right hard palate with palatal bone resorption (white arrows). D-F Images revealed the formation of new bone (white arrows) in the right hard palate 18 months after surgery. A and D: Transverse plane, B and E: Sagittal plane, C and F: Coronal plane. L: left The patient underwent surgical treatment under general anesthesia, and the right palatal tumor was resected, with negative margins confirmed by frozen biopsy. During surgery, we aimed to achieve complete resection of the tumor with a margin of 5 mm beyond its boundary. After the tumor was removed, the palatal bone was found to be intact, and no communication between the oral cavity and nasal cavity was observed. On histopathological evaluation, the tumor was encapsulated within the submucosa, and spindle-shaped tumor cells arranged haphazardly around blood vessels. The hypercellular area was larger than the hypocellular area. In addition, immunohistochemical analysis revealed that the tumor was positive for STAT6, CD34 and Bcl-2. Negative staining was observed for CD99, S-100, CK and Desmin, and focal positive staining was observed for SMA. The percentage of Ki-67-positive cells was 5%. Moreover, the nuclear mitotic count was 2–3 mitoses/10 HPF, and no necrosis was noted. According to the histopathological examination and immunohistochemical analysis, the diagnosis was SFT (low risk) in the right hard palate. On routine examination 18 months after surgery, there were no indications of new tumors in the surgical region, and the mucosa appeared normal except for scar formation. Furthermore, a CBCT scan revealed the formation of new bone in the palate (Fig. 2D-F). There was no evidence of recurrence or metastasis in this patient. The patient was satisfied with the surgical outcome and had a good quality of life. Patient 3 A 61-year-old Chinese female was admitted to the oral and maxillofacial department with a mass in the left hard palate. She reported that the painless mass had persisted for two years. In the last two months, she reported that the mass had been growing slowly, accompanied by unclear speech and discomfort while swallowing. A rubbery oval-shaped mass was located on the left palate, approximately 4.0 cm × 3.5 cm in size with distinct boundaries. The overlying mucosa was normal. No neck lymph nodes were detected. Moreover, CT analysis (Fig. 3) revealed a slightly higher-density circular image with clear borders in the left palate, accompanied by compression bone absorption in the left hard palate. The presence of smooth borders and the formation of sclerotic lines in the bone absorption region suggest that bone resorption was a result of tumor compression. No significant abnormalities were observed in the surrounding soft tissue or bilateral maxillary sinuses. The tumor was diagnosed as a “pleomorphic adenoma” based on clinical and radiological examinations.Fig. 3The CT images exhibited a mass (with black arrows) locating on the left palate with bone resorption (white arrow). A: Transverse plane, B: Coronal plane, L: left The CT images exhibited a mass (with black arrows) locating on the left palate with bone resorption (white arrow). A: Transverse plane, B: Coronal plane, L: left The patient underwent wide local excision under general anesthesia. Intraoperatively, the palatal bone was found to be intact, and there was no communication between the oral cavity and the nasal cavity. Pathological examination revealed that the tumor had distinct borders, and spindle-shaped tumor cells were scattered within collagen fiber bundles. Abundant blood vessels were observed within the tumor, with a distinct alternating pattern of hypocellular and hypercellular areas. Furthermore, the immunohistochemistry results revealed positive expression of STAT6, CD34 and Bcl-2 in the tumor. The percentage of Ki-67-positive cells was 10%. However, the tumor was weakly positive for CD99 and negative for S-100, CK, Desmin, and SMA. No evidence of necrosis, nuclear pleomorphism, or atypia was observed. The patient was diagnosed with a benign SFT based on the histological and immunohistochemical features. No evidence of recurrence or metastasis was noted during the 100 months of follow-up. Patient 4 A 33-year-old Chinese man presented with a one-week history of an asymptomatic mass in the left submandibular region. The lesion was well defined, oval-shaped and firm. The overlying skin was normal. The tongue movement and feeling were normal, with no facial paralysis appearance. No obvious enlargement lymph nodes were found in bilateral submandibular space and neck region. The Magnetic Resonance images (MRI) showed an elliptical abnormal signal with clear borders was seen in submandibular space, approximately 3.7 × 2.6 cm in size, with isointensity on T1-weighted imaging (T1WI) (Fig. 4A), hyperintensity on T1-weighted imaging (T2WI) (Fig. 4B) and diffusion-weighted imaging (DWI). The lesion was clearly demarcated from the right submandibular gland. Meanwhile, color ultrasonography examination found a hypoechoic mass with abundant blood flow signals adjacent to the right submandibular gland, which was approximately 3.6 × 2.8 cm in size (Fig. 4C). Based on these data, a clinical diagnosis of “lymphadenitis or schwannoma” was made.Fig. 4The MRI results for Patient 4 revealed an elliptical abnormal signal located in the right submandibular region, with isointensity on T1WI (A) and hyperintensity on T2WI (B). C Color ultrasonography revealed abundant blood flow signals in the mass. L: Left The MRI results for Patient 4 revealed an elliptical abnormal signal located in the right submandibular region, with isointensity on T1WI (A) and hyperintensity on T2WI (B). C Color ultrasonography revealed abundant blood flow signals in the mass. L: Left The tumor was excised under general anesthesia. At surgery, a well-encapsulated firm mass was identified without involving the submandibular gland. No invasion of surrounding soft tissue was observed during the operation. Grossing, the tumor was measured 3.5 × 2.8 cm in size with a grayish-white cut surface. On histological examination, the lesion was well-circumscribed. The tumor was composed of spindle or oval cells arranged haphazardly with abundant blood vessels. Numbers of blood vessels had typical “staghorn” vascular structures. There were both hypocellular and hypercellular areas in the tumor. Meanwhile, collagenization was visible in the stroma. Immunohistochemical analysis showed that the tumor was strongly positive for STAT6, CD34, CD99 and Bcl-2, but negative for CK, SMA, Desmin and S-100. The positive Ki-67 ratio was 10%. Mitoses were fewer than 4 mitoses/10 high power fields. No evidence of necrosis, nuclear pleomorphism, or atypia was observed. It was diagnosed as benign SFT according to the histology and immunohistochemical features. No evidence of recurrence or metastasis was noted during the 10 months follow-up postoperatively. Patient 5 A 50-year-old Chinese female came to our department with a neoplasm in left mouth floor. The patient incidentally discovered the growth one month ago. Subsequently, she felt that the mass had slightly increased in size but denied any pain or numbness symptoms. Intraoral examination revealed a pink soft mass with distinct borders was in left mouth floor. It was approximately 2.0 × 1.5 in size, movable and with tender texture. The covering mucosa was normal. Furthermore, MRI scan showed that an elliptical abnormal signal located in left sublingual gland, measuring approximately 2.1 × 1.1 cm. It appeared isointensity on T1WI (Fig. 5A), hyperintensity on T2WI (Fig. 5B), and showed heterogeneous hyperintensity on DWI. The mass boundaries were clear. Based on above data, a clinical diagnosis of “pleomorphic adenoma or schwannoma” was made.Fig. 5The MRI images for Patient 5 showed an elliptical abnormal signal located in left sublingual gland, with isointensity on T1WI (A) and hyperintensity on T2WI (B). L: Left The MRI images for Patient 5 showed an elliptical abnormal signal located in left sublingual gland, with isointensity on T1WI (A) and hyperintensity on T2WI (B). L: Left The patient suffered the surgical excision of the neoplasm and sublingual gland. Intraoperative examination found a spherical mass with intact capsule involved left sublingual gland. A size of 2.0 × 1.4 cm nodule was seen on the cut surface of the sublingual gland. Microscopely, spindle-shaped tumor cells and amount blood vessels were noted. Cells exhibited a haphazard arrangement with hypercellularity in some areas. The mitotic count was approximately 2 mitoses per 10 high-power fields. The tumor exhibited vascular growth and collagenization in the stroma. Immunohistochemical results showed tumor was positive for CD34, Bcl-2, CD99, STAT6, negative for CK, S-100, Desmin and SMA. The positive ratio of Ki-67 was approximately 5%. The pathological diagnosis was SFT in left sublingual gland. No evidence of recurrence or metastasis was noted during the 70 months follow-up postoperatively. Patient 6 A 53-year-old Chinese female was admitted to hospital due to an asymptomatic neoplasm on right cheek for 2 years. Physical examination revealed facial asymmetry in the patient. The tough neoplasm was about 4.0 × 3.0 cm in size, with clear boundary. The covering oral mucosa and skin were normal. Specially, the opening of parotid duct was located on the surface of the mass, with normal salivary secretion. The mass did not affect the opening of the mouth. No significantly enlarged lymph nodes were detected. The MRI scan suggested an oval mass measuring approximately 4.2 × 3.3 cm in right cheek. It exhibited isointensity on T1WI (Fig. 6A), hyperintensity on T2WI (Fig. 6B), and heterogeneous hyperintensity on DWI. In addition, blood vessel images were seen within well-circumscribed nodule. Then, a clinical diagnosis of “neurilemmoma or leiomyoma” was made.Fig. 6The MRI images revealed an abnormal signal located in right cheek with isointensity on T1WI (A) and hyperintensity on T2WI (B). L: Left The MRI images revealed an abnormal signal located in right cheek with isointensity on T1WI (A) and hyperintensity on T2WI (B). L: Left The patient suffered the surgical operation, during which the tumor was completely removed and the parotid duct was separated and protected. The firm tumor was approximately 3.0 × 3.5 cm with intact capsule. Under the microscope, the tumor cells were spindle-shaped, few adipose tissue and abundant blood vessels were also found in tumor stroma. Mitotic count was 1 mitosis /10 high power fields. The tumor showed positivity for STAT6, Bcl-2 and CD34, weak positivity for CD99. While, stains with CK, S-100, Desmin, SMA were negative. The final pathological diagnosis was SFT in right cheek. There was no recurrence or metastasis within 52 months follow-up period. Patient 7 A 25-year-old Chinese female presented to our outpatient clinic due to an occasionally found neoplasm on the left cheek two years ago. Initially, it was the size of a soybean and gradually increased. There was no pain or numbness. The mouth opening and swallowing were normal. Physical examination showed that a well-circumscribed round mass measuring approximately 2.0 × 2.0 cm was present on the left cheek. It had a firm texture and good mobility. The overing skin was intact. No obvious enlargement of the lymph nodes in the maxillofacial area was observed. The MRI scan revealed a round abnormal signal lesion with clear borders, and a size of approximately 1.6 × 1.4 cm. It located along the anterior and inferior border of the masseter, with isointensity on T1WI (Fig. 7A), hyperintensity on T2WI (Fig. 7B) and DWI. Ultrasonography (Fig. 7C) showed a hypoechoic and well-circumscribed nodule near the masseter. The rich blood flow signals had been seen within the tumor. Based on clinical presentation and imaging studies, the clinical diagnosis was "enlarged lymph node or neurilemmoma ".Fig. 7The MRI images showed an abnormal signal located in right cheek with isointensity on T1WI (A) and hyperintensity on T2WI (B). (C) Color ultrasonography revealed rich blood flow signals in the neoplasm. L: Left The MRI images showed an abnormal signal located in right cheek with isointensity on T1WI (A) and hyperintensity on T2WI (B). (C) Color ultrasonography revealed rich blood flow signals in the neoplasm. L: Left The patient suffered the surgical operation under general anesthesia. During the surgery, we found a grayish-white nodule with intact capsule, measuring approximately 2.3 × 1.6 × 1.5 cm in size. The cut-section of mass was also grayish-white with local myxoid change. Microscopically (Fig. 9A and B), tumor cells were spindle-shaped with diffuse growth, and alterations of hypocellular and hypercellular areas were clear. Abundant blood vessels could be seen within the tumor tissue. Moreover, a few nuclear divisions could be observed, mitotic count was 5 mitoses per 50 high power fields, and there was increased collagen tissue in stroma. Immunohistochemistry staining (Fig. 9C-G) results showed that the tumors cells were positive to Ki-67, CD34, Bcl-2, STAT6 and CD99, but negative to CK, S-100, Desmin and SMA. The positive rate of Ki-67 was 15%. A diagnosis of SFT in the left cheek was finally made. In the 35 months of postoperative follow-up, there was no evidence of local recurrence or metastasis. Patient 8 A 56-year-old Chinese female admitted to our hospital with a nodule in right cheek. Patient discovered a pea-sized lump under the right buccal mucosa during eating six weeks ago. Slight pain was experienced when pressing the mass. There was no numbness. Intraoral examination revealed a tough oval-shaped mass located under the right buccal mucosa with distinct borders, approximately 2.0 × 2.0 cm in size. The neoplasm was firm in texture and movable, with normal oral mucosa on the surface. The MRI resulted an elliptical abnormal signal with clear borders located anterior to the mandibular ramus, approximately 2.0 × 1.5 cm in size, with hypointensity on T1WI (Fig. 8A) and isointensity with focal hyperintensity on T2WI (Fig. 8B). Rely on clinical and radiological examinations, a clinical diagnosis of “neurofibroma or liomyoma” was made.Fig. 8The MRI results revealed a mass locating anterior to right mandibular ramus. It was isointensity on T1WI (A) with focal hyperintensity on T2WI (B). L: left The MRI results revealed a mass locating anterior to right mandibular ramus. It was isointensity on T1WI (A) with focal hyperintensity on T2WI (B). L: left The patient suffered the surgical operation to remove the neoplasm. In surgery, the mass was lied on the surface of the buccal fat pad, with a hard texture and intact capsule. Furthermore, the pathological examination showed the tumor was composed of spindle cell arranged haphazardly, accompanied by abundant vasculature displaying a "staghorn" appearance. There was an alternating pattern of hypocellular and hypercellular areas. No significant nuclear mitosis or necrosis were found. While the immunohistochemical analysis found the tumor was positive for STAT6, CD34 and Bcl-2, uneven positive for CD 99, negative for SMA, CK and Desmin. The positive Ki-67 ratio was about 2%. Finally, a diagnosis of SFT (low risk) in right cheek was made. Patient 9 A 73-year-old Chinese male presented to our hospital with a neoplasm on the back of his tongue. The patient did not report any pain or numbness, and tongue mobility was normal. Intraoral examination revealed a spherical neoplasm approximately 1.0 × 1.0 cm in size at the root of tongue. The mass had a moderate texture with smooth surface and distinct borders. No enlarged lymph nodes were palpable in the bilateral neck or submandibular regions. According to the clinical examinations, a clinical diagnosis of “fibrous hyperplasia, neurofibroma or liomyoma” was made. The patient received surgical operation under general anesthesia. Pathological examination revealed spindle-shaped tumor cells with collagen fibers in the stroma. The tumor boundaries were still clear. Moreover, immunohistochemical analysis showed tumor cells were positive for CD34, CD99 and Bcl-2, were negative for STAT6, S-100, Desmin, SMA and CK. The percentage of Ki-67-positive cells was 3%. Depend on the histopathological examination and immunohistochemical analysis, the final diagnosis was SFT in tongue. Histopathology The morphological features of SFT are various, yet they share certain characteristics, such as the spindled to ovoid tumor cells arranged irregularly within collagenous stroma, along with abundant blood vessels [11]. Some other specific features consist of lipomatous differentiation (as observed in Patient 6), myxoid alteration (as seen in Patient 7), infiltrative growth (as seen in Patient 1), presence or absence of nuclear atypia, and necrosis. All cases in our study were diagnosed as benign SFT. Generally, benign SFTs were characterized by well-circumscribed capsules with homogeneous grayish-white cut surface, and had firm to rubbery consistency. But excepted for Patient 1, the indistinct borders resulted in the pathologist diagnosing the tumor as benign but displaying invasive growth behavior. Microscopically, the tumor cells were not arranged in a fixed pattern, they might arrange in haphazard pattern, storiform pattern or fascicular pattern. And the admixture of hypocellular and hypercellular areas could been seen in the SFT. Surrounding the cells, the stroma was collagenized, and amount collagen fibers could be detected especially in hypocellular area (Fig. 9A). Additionally, SFT was characterized by a high presence of blood vessels, which might present a typical “staghorn” appearance (Fig. 9B). During immunohistochemical analysis, Ki67, a marker indicative of cellular proliferation, was a standard parameter. Usually, benign tumors displayed lower Ki67 levels, with patient 7 exhibiting a Ki67 positivity rate of about 15% (Fig. 9C). Furthermore, STAT6, CD34, Bcl-2 and CD99 were always been tested for SFT diagnosis. In SFTs, the inversion fusion occurred between STAT6 and NAB2 resulting in NAB2-STAT6 expression [12, 13]. And the positive immunostaining of STAT6 served as a diagnostic marker for SFT (Fig. 9D). For CD34, a cell surface marker frequently used to identify and characterize vascular endothelial cells and mesenchymal cells, tended to exhibit positive expression in SFTs due to their rich vascularity (Fig. 9E). Bcl-2 functioned as an anti-apoptotic protein involved in cell apoptosis and tumor growth control. CD99 might be expressed in diverse epithelial and mesenchymal tumors. Positive expression of Bcl-2 (Fig. 9F) and CD99 (Fig. 9G) were also beneficial for diagnosing SFT. It was worth noting that in specific instances, any aforementioned indicators might exhibit negative expression. In this series, STAT6 was negative in Patient 9, CD99 was negative in Patient 2 and weakly positive in Patients 3 and 6 (Table 1). Other markers, S-100, Desmin, and CK were negative in all cases, and SMA was weakly positive in Patient 1 and positive in Patient 2 (Table 1).Fig. 9Histological analysis and immunohistochemical analysis of tumor (Patient 7). The HE stained (100 ×) showed, A the spindle cells were arranged haphazardly in a fascicular pattern, and there was admixture of hypercellular and hypocellular areas. B The typical “staghorn” vascular structures were visible. While the immunohistochemical analysis showed positive rate of Ki-67 was 15% (C, 100 ×). Other indicators, such as STAT6 (D), CD34 (E), Bcl-2 (F), and CD99 (G) revealed positive staining (200 ×)Table 1Clinical and immunohistochemical features for the nine cases in this reportgenderagelocationSTAT6CD34CD99Bcl-2CKDesminS-100SMAKi-67follow-up periodrecurrencePatient 1female60mandible + + + + --- ± + , < 1%12 monthsnoPatient 2male44palate + + - + --- + + , 5%18 monthsnoPatient 3female61palate + + ± + ---- + , 10%100 monthsnoPatient 4male33submandibular region + + + + ---- + , 10%10 monthsnoPatient 5female50sublingual gland + + + + ---- + , 5%70 monthsnoPatient 6female53cheek + + ± + ---- + , 3%52 monthsnoPatient 7female25cheek + + + + ---- + , 15%35 monthsnoPatient 8female56cheek + + + + ---- + , 2%1 monthnoPatient 9male73tongue- + + + ---- + , 3%75 monthsno Histological analysis and immunohistochemical analysis of tumor (Patient 7). The HE stained (100 ×) showed, A the spindle cells were arranged haphazardly in a fascicular pattern, and there was admixture of hypercellular and hypocellular areas. B The typical “staghorn” vascular structures were visible. While the immunohistochemical analysis showed positive rate of Ki-67 was 15% (C, 100 ×). Other indicators, such as STAT6 (D), CD34 (E), Bcl-2 (F), and CD99 (G) revealed positive staining (200 ×) Table 1Clinical and immunohistochemical features for the nine cases in this reportgenderagelocationSTAT6CD34CD99Bcl-2CKDesminS-100SMAKi-67follow-up periodrecurrencePatient 1female60mandible + + + + --- ± + , < 1%12 monthsnoPatient 2male44palate + + - + --- + + , 5%18 monthsnoPatient 3female61palate + + ± + ---- + , 10%100 monthsnoPatient 4male33submandibular region + + + + ---- + , 10%10 monthsnoPatient 5female50sublingual gland + + + + ---- + , 5%70 monthsnoPatient 6female53cheek + + ± + ---- + , 3%52 monthsnoPatient 7female25cheek + + + + ---- + , 15%35 monthsnoPatient 8female56cheek + + + + ---- + , 2%1 monthnoPatient 9male73tongue- + + + ---- + , 3%75 monthsno Clinical and immunohistochemical features for the nine cases in this report Discussion Solitary fibrous tumors (SFTs) occurring in the oral and maxillofacial region are extremely rare. We reviewed surgical cases in our department from the past nine years and identified only nine patients with SFTs. Among the nine patients in this study, three were male, and six were female. The SFTs were more common in females, which was consistent with the findings of another study, which reported that benign SFTs were more prevalent in females (55.9%) [10]. The average age of the patients was 50.6 years, ranging from 25 to 73 years. SFTs in the oral and maxillofacial regions most commonly occur in the buccal mucosa, followed by the tongue and palate [10, 14]. Our research yielded similar results, with 3 cases (33.3%) occurring in the buccal area, 2 cases (22.2%) occurring in the palate, and 1 case each in the other four areas (Table 1). Notably, the origin of the tumor in Patient 1 was controversial. There were two possible origins: either the tumor originated from the mandible bone marrow or periodontal tissue and then broke the lingual wall of the mandible, or the tumor originated from the soft tissues in the floor of the mouth, gradually eroding the mandible and tooth roots. As previously mentioned, the pattern of bone destruction in this patient was different from those in Patient 2 and Patient 3. Moreover, according to the radiological examination, the lesion resembled an intraosseous tumor. Therefore, we leaned toward the first origin. Intraosseous SFTs are extremely rare. To the best of our knowledge, only six cases of intraosseous SFT have been reported [15], and Patient 1 may be the first case of SFT arising in mandible. SFT within mandible was asymptomatic, posing challenges for patient identification. Radiologically, it could be mistaken for periapical cysts, keratocysts, giant cell tumor, ameloblastoma or myxoma. Its distinctive location also increased the likelihood of misdiagnosis in pathology. Furthermore, the recurrence rate of oral SFTs is approximately 0.7% [10], which is lower than that of systemic SFTs (57%) [16, 17]. However, no recurrence was found during the follow-up period in our study. It is difficult to assist in the clinical diagnosis of SFT through imaging examinations such as CT, MRI and ultrasonography, as it is a tumor with atypical clinical symptoms. Benign SFTs generally exhibit well-defined borders on MR or CT images. When a tumor occurs in an area surrounded by soft tissue without any bony constraints on tumor growth, it typically appears as an analogous round well-circumscribed mass on imaging. Therefore, it is crucial to distinguish SFT from other tumors, such as pleomorphic adenoma, mucocele, fibrous hyperplasia, lipoma, neurofibroma, neurilemmoma and liomyoma [11]. For begin SFTs, the tumors in Patient 4 to Patient 7 exhibited isointensity on T1WI and hyperintensity on T2WI and DWI. Uniquely, the tumor in Patient 8 exhibited hypointensity on T1WI, isointensity with focal hyperintensity on T2WI (Fig. 8), and isointensity on DWI. These results might be useful in the diagnosis of SFTs through MRI examination. As lipoma usually exhibit hyperintensity on T1WI and isointensity on T2WI, and mucocele may have a more significant hyperintensity on T2WI. Increased angiogenesis is a critical characteristic feature of SFTs. Reports have shown that SFTs could exhibit local neovascularization within the tumor or vascular encasement around the tumor on contrast-enhanced CT images or MR images [18, 19]. In our study, color ultrasonography for Patient 4 revealed abundant blood flow signals in the hypoechoic mass (Fig. 4C). A similar situation also occurred in Patient 7 (Fig. 7C). Although only these two patients underwent ultrasonography, we believe that non-invasive ultrasonography is meaningful for the diagnosis of SFTs, especially for patients with tumors located outside the oral cavity. Scholars had proposed that intraoperative bleeding should be considered during SFT surgery [18]. However, in our patients, there was no abnormal increase in intraoperative bleeding. We proposed two potential explanations. First, the tumors in these patients had intact capsules. Second, the blood vessels supplying the facial tumors were relatively delicate, and the tumors did not involve major vessels. The oral and maxillofacial regions contain abundant hard tissue. Clinically, CT and X-ray examinations can efficiently reflect the condition of bone, as observed in the two patients with hard palatal lesions and the patient with a mandibular lesion. Benign SFTs can cause bone resorption by exerting pressure on the surrounding bones. Typically, the edges of the bone defect area appear smooth, and sclerotic lines are visible. The CT images of Patient 3 showed typical signs of compressive bone resorption (Fig. 3). For Patient 2, the edges of the bone lesion were smooth on the coronal CT image but irregular on the transverse and sagittal planes (Fig. 2). On the basis of the CT images, we initially believed that it could be adenoid cystic carcinoma or other malignant tumors of minor salivary gland. The X-ray and CT images for Patient 1 (Fig. 1) revealed a large bone defect in the mandible with jagged edges and without a distinct sclerotic line. In the lesion, the lingual bone of the mandible was damaged, the buccal bone was thin, and tooth root resorption was observed. We initially suspected that the tumor was an ameloblastoma or giant cell tumor based on the invasive behavior of the tumor on the images. However, the pathological results for Patient 1 and Patient 2 both confirmed diagnoses of benign SFTs. The irregularity of the lesion edges might be caused by the involvement of the tooth roots, which could incorrectly suggest that the tumor exhibits strong invasiveness. According to the literature and our findings, immunohistochemistry analysis is mandatory in the pathological diagnosis of SFTs [19]. The typical markers include CD34, CD99, Bcl-2 and STAT6. Notably, any one of these four markers may be negative in certain individual cases. Although the use of STAT6 in SFT diagnosis is relatively limited, nuclear STAT6 positivity in tumor cells has been identified as the most sensitive and specific marker for SFTs [7–9]. Generally, the genes encoding STAT6 and NAB2 are located close to each other on chromosome band 12q13 [6, 12]. However, in SFTs, inversion fusion occurs between STAT6 and NAB2, with STAT6 replacing the carboxy-terminal repressor domain of NAB2, resulting in NAB2-STAT6 expression [12, 13]. The expression of NAB2-STAT6 is positively associated with cell proliferation and is unrelated to tumor malignancy and prognosis [12, 13]. In certain instances, STAT6 expression could be negative in SFTs, similar to Patient 4 (Table 1). Another study reported that in dedifferentiated SFTs, the NAB2-STAT6 fusion was expressed only at the gene level. Tumors might be negative for STAT6 on immunohistochemical testing due to the absence or loss of the chimeric protein [20, 21]. This situation highlights the limitations of immunohistochemistry. Furthermore, in our study, the vascular endothelial cell-related protein CD34 was positive in all cases, but there was significant variability in CD99 expression, which was in similar with other reports [11]. The anti-apoptotic protein Bcl-2 was also positively expressed in all cases. Other markers, such as SMA, S-100 protein, Desmin, and CK, were often negative on immunohistochemistry [22]. In the cases in this article, SMA was partially positive in two cases (Table 1). At present, the primary treatment approach for SFTs is complete surgical removal of the tumor within safe margins. Some papers have mentioned the use of radiotherapy and anti-angiogenic treatment (chemotherapy) for SFTs occurring outside the oral cavity, especially in patients with metastasis or tumors that could not be surgically removed [16, 23–25]. In this study, surgical intervention was performed for all patients. Since the tumors had intact capsules during the operation and the pathological diagnoses indicated benign tumors, there was no need for extensive resection during the operation, and postoperative radiotherapy and chemotherapy were not administered. Although the oral and maxillofacial region has a relatively small scope, its anatomical structures are complex. Tissue injury in this area can greatly affect a patient's quality of life. Therefore, during surgery, particular attention should be given to the protection of the surrounding tissues, especially the nerves. Conclusions The SFTs in the oral and maxillofacial region are rare, with a predominance of benign cases. The pathological diagnosis of SFTs has now become relatively well established, incorporating histological features and immunohistochemical results for STAT6, CD34, CD99, and Bcl-2. The primary treatment approach remains surgical excision, with emphasis on the protection of critical anatomical structures and the restoration of function. However, there is still no definitive diagnostic method for distinguishing SFTs other than pathological analysis. As evidenced by the cases in this study, the radiological manifestations of SFTs can be diverse. The mass can also cause resorption of surrounding bone tissue with edges generally smooth, but irregular and unclear edges may appear in isolated cases. Therefore, we emphasize the importance of advancing the knowledge of SFTs and including SFTs in a routine differential diagnosis, which will facilitate the development of appropriate clinical treatment strategies.